ARCHIVES

FDA Says ImClone Data Insufficient To Evaluate Colorectal Cancer Drug C225.

This article is from The Cancer Letter archive.

Vol. 28 No. | March 8, 2002

Download PDF Visit The Full Archive

Related Articles

Avastin May Trigger Two FDA Decisions: One On Approval, Another On Withdrawal

September 3, 2010

Funding opportunities listed.

April 30, 2004

Barnett Kramer Retires From NIH

January 7, 2011

NTP Board Gives Concept Approvals

December 4, 1981

In Brief: NSABP Proposal Selected for Tamoxifen Trials; NIH Building To Be Named After Silvio Conte

March 8, 1991

AC To Refuse Government Help In Future Projects

November 24, 1978